97 related articles for article (PubMed ID: 2019454)
1. Thioredoxin reductase activity at the surface of human primary cutaneous melanomas and their surrounding skin.
Schallreuter KU; Jänner M; Mensing H; Breitbart EW; Berger J; Wood JM
Int J Cancer; 1991 Apr; 48(1):15-9. PubMed ID: 2019454
[TBL] [Abstract][Full Text] [Related]
2. Calcium transport and regulation in human primary and metastatic melanoma.
Schallreuter KU; Wood JM; Ehrke C; Lemke R
Biochim Biophys Acta; 1992 Nov; 1160(1):127-33. PubMed ID: 1329982
[TBL] [Abstract][Full Text] [Related]
3. The activity and purification of membrane-associated thioredoxin reductase from human metastatic melanotic melanoma.
Schallreuter KU; Wood JM
Biochim Biophys Acta; 1988 Oct; 967(1):103-9. PubMed ID: 2844280
[TBL] [Abstract][Full Text] [Related]
4. Expression and prognostic significance of Cathepsin L in early cutaneous malignant melanoma.
Stabuc B; Mrevlje Z; Markovic J; Stabuc-Silih M
Neoplasma; 2006; 53(3):259-62. PubMed ID: 16652198
[TBL] [Abstract][Full Text] [Related]
5. The stereospecific suicide inhibition of human melanoma thioredoxin reductase by 13-cis-retinoic acid.
Schallreuter KU; Wood JM
Biochem Biophys Res Commun; 1989 Apr; 160(2):573-9. PubMed ID: 2719682
[TBL] [Abstract][Full Text] [Related]
6. Margins of excision for cutaneous melanoma of the eyelid skin: the Collaborative Eyelid Skin Melanoma Group Report.
Esmaeli B; Youssef A; Naderi A; Ahmadi MA; Meyer DR; McNab A;
Ophthalmic Plast Reconstr Surg; 2003 Mar; 19(2):96-101. PubMed ID: 12644753
[TBL] [Abstract][Full Text] [Related]
7. New aspects in the pathophysiology of cutaneous melanoma: a review of the role of thioproteins and the effect of nitrosoureas.
Schallreuter KU; Wood JM
Melanoma Res; 1991; 1(3):159-67. PubMed ID: 1841712
[TBL] [Abstract][Full Text] [Related]
8. The role of calcium in the regulation of free radical reduction by thioredoxin reductase at the surface of the skin.
Schallreuter KU; Pittelkow MR; Gleason FK; Wood JM
J Inorg Biochem; 1986; 28(2-3):227-38. PubMed ID: 2433392
[TBL] [Abstract][Full Text] [Related]
9. Calcium regulates thioredoxin reductase in human metastatic melanoma.
Schallreuter KU; Wood JM
Biochim Biophys Acta; 1989 Aug; 997(3):242-7. PubMed ID: 2765562
[TBL] [Abstract][Full Text] [Related]
10. Increased activity of cathepsin B in fibroblasts isolated from primary melanoma in comparison to fibroblasts from normal skin.
Ulmer A; Körber V; Schmid H; Fierlbeck G
Exp Dermatol; 1998 Feb; 7(1):14-7. PubMed ID: 9517917
[TBL] [Abstract][Full Text] [Related]
11. The Association Between Excision Margins and Local Recurrence in 11,290 Thin (T1) Primary Cutaneous Melanomas: A Case-Control Study.
MacKenzie Ross AD; Haydu LE; Quinn MJ; Saw RP; Shannon KF; Spillane AJ; Stretch JR; Scolyer RA; Thompson JF
Ann Surg Oncol; 2016 Apr; 23(4):1082-9. PubMed ID: 26561405
[TBL] [Abstract][Full Text] [Related]
12. Azelaic acid as a competitive inhibitor of thioredoxin reductase in human melanoma cells.
Schallreuter KU; Wood JM
Cancer Lett; 1987 Sep; 36(3):297-305. PubMed ID: 3652030
[TBL] [Abstract][Full Text] [Related]
13. Urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 and type 2 in stage I malignant melanoma.
Stabuc B; Markovic J; Bartenjev I; Vrhovec I; Medved U; Kocijancic B
Oncol Rep; 2003; 10(3):635-9. PubMed ID: 12684636
[TBL] [Abstract][Full Text] [Related]
14. Thioredoxin reductase activity in Hermansky-Pudlak syndrome: a method for identification of putative heterozygotes.
Schallreuter KU; Witkop CJ
J Invest Dermatol; 1988 Mar; 90(3):372-7. PubMed ID: 3346559
[TBL] [Abstract][Full Text] [Related]
15. Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome.
Garg K; Maurer M; Griss J; Brüggen MC; Wolf IH; Wagner C; Willi N; Mertz KD; Wagner SN
Hum Pathol; 2016 Aug; 54():157-64. PubMed ID: 27107457
[TBL] [Abstract][Full Text] [Related]
16. Association of Patient Risk Factors and Frequency of Nevus-Associated Cutaneous Melanomas.
Haenssle HA; Mograby N; Ngassa A; Buhl T; Emmert S; Schön MP; Rosenberger A; Bertsch HP
JAMA Dermatol; 2016 Mar; 152(3):291-8. PubMed ID: 26536613
[TBL] [Abstract][Full Text] [Related]
17. Free radical reduction by thioredoxin reductase at the surface of normal and vitiliginous human keratinocytes.
Schallreuter KU; Pittelkow MR; Wood JM
J Invest Dermatol; 1986 Dec; 87(6):728-32. PubMed ID: 2431070
[TBL] [Abstract][Full Text] [Related]
18. Expression of dicarbonyl/L-xylulose reductase (DCXR) in human skin and melanocytic lesions: morphological studies supporting cell adhesion function of DCXR.
Cho-Vega JH; Vega F; Schwartz MR; Prieto VG
J Cutan Pathol; 2007 Jul; 34(7):535-42. PubMed ID: 17576332
[TBL] [Abstract][Full Text] [Related]
19. The Value of High-frequency 20 MHz Ultrasonography for Preoperative Measurement of Cutaneous Melanoma Thickness.
Kozárová A; Kozár M; Tonhajzerová I; Pappová T; Minariková E
Acta Dermatovenerol Croat; 2018 Apr; 26(1):15-20. PubMed ID: 29782294
[TBL] [Abstract][Full Text] [Related]
20. Nuclear PTEN expression and clinicopathologic features in a population-based series of primary cutaneous melanoma.
Whiteman DC; Zhou XP; Cummings MC; Pavey S; Hayward NK; Eng C
Int J Cancer; 2002 May; 99(1):63-7. PubMed ID: 11948493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
